Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
46.7M
-
Number of holders
-
83
-
Total 13F shares, excl. options
-
24.7M
-
Shares change
-
+314K
-
Total reported value, excl. options
-
$172M
-
Value change
-
+$978K
-
Number of buys
-
49
-
Number of sells
-
-28
-
Price
-
$6.98
Significant Holders of 4D Molecular Therapeutics, Inc. - Common Stock, par value $0.0001 per share (FDMT) as of Q2 2022
94 filings reported holding FDMT - 4D Molecular Therapeutics, Inc. - Common Stock, par value $0.0001 per share as of Q2 2022.
4D Molecular Therapeutics, Inc. - Common Stock, par value $0.0001 per share (FDMT) has 83 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 24.7M shares
of 46.7M outstanding shares and own 52.85% of the company stock.
Largest 10 shareholders include BVF INC/IL (4.01M shares), VIKING GLOBAL INVESTORS LP (3.94M shares), Deep Track Capital, LP (3.14M shares), BlackRock Inc. (2.18M shares), ArrowMark Colorado Holdings LLC (1.42M shares), VANGUARD GROUP INC (1.32M shares), Aquilo Capital Management, LLC (862K shares), FMR LLC (700K shares), Octagon Capital Advisors LP (633K shares), and STATE STREET CORP (633K shares).
This table shows the top 83 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.